Filtros de búsqueda

Lista de obras de Ramon Colomer

18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

artículo científico publicado en 2016

3D Assessment of Lymph Nodes vs. RECIST 1.1.

artículo científico publicado en 2011

A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms

artículo científico publicado en 2015

A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer

scientific article published on 01 May 2019

A new multidisciplinary Spanish Working Group on Cancer Biomarkers: presentation and aims

artículo científico publicado en 2012

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.

artículo científico publicado en 2011

A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer

scientific article published on 14 December 2019

Advanced breast cancer clinical nursing curriculum: review and recommendations

artículo científico publicado en 2017

Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase Inhibitors.

artículo científico publicado en 2016

BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study

scientific article published on 21 December 2019

BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer.

artículo científico publicado en 2008

Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

artículo científico publicado en 2017

Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain.

artículo científico publicado en 2004

Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors.

artículo científico publicado en 2003

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.

artículo científico publicado en 2010

CCR5 expression influences the progression of human breast cancer in a p53-dependent manner

artículo científico publicado en 2003

Cancer care in rural areas.

artículo científico publicado en 2004

Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses

artículo científico publicado el 15 de marzo de 1992

Congress of the Spanish Society of Medical Oncology (SEOM) in Barcelona

scientific article published on 01 November 2009

Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.

artículo científico publicado en 2011

Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

artículo científico publicado en 2018

Critically short telomeres and toxicity of chemotherapy in early breast cancer

artículo científico publicado en 2017

Current controversies in the management of early breast cancer.

artículo científico publicado en 2007

Dermatofibrosarcoma Protu-Berans with Lung Metastasis Requiring Pneumonectomy

artículo científico publicado en 2015

Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells

scientific article published on 01 November 2004

Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease?

artículo científico publicado en 2002

Dose and dose intensity effect of adjuvant anthracycline-based chemotherapy in early breast cancer: a retrospective analysis

artículo científico publicado en 2004

EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt

artículo científico publicado en 2007

Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene.

artículo científico publicado en 2005

Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

scientific article published on 01 November 2019

Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.

artículo científico publicado en 2007

Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.

artículo científico publicado en 2014

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study

artículo científico publicado en 2020

Giacomo Castelvetro's salads. Anti-HER2 oncogene nutraceuticals since the 17th century?

artículo científico publicado en 2008

High circulating HER2 extracellular domain levels correlate with reduced efficacy of an aromatase inhibitor in hormone receptor-positive metastatic breast cancer: a confirmatory prospective study

artículo científico publicado en 2007

Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients

scientific article published on 22 January 2019

In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours.

artículo científico publicado en 2013

In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

artículo científico publicado en 2018

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

artículo científico publicado en 2004

Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.

artículo científico publicado en 2005

Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.

artículo científico publicado en 2004

Is Metastatic Disease the Best Setting for Cost-Effectiveness Studies?

artículo científico publicado en 2016

Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma

artículo científico publicado el 1 de enero de 1997

Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells.

artículo científico publicado en 2008

Management of metastatic breast cancer: are we prepared to cope with our own success?

artículo científico publicado en 2004

Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells

artículo científico publicado en 2017

Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents.

artículo científico publicado en 2016

Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement

artículo científico publicado en 2019

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial

artículo científico

New synthetic inhibitors of fatty acid synthase with anticancer activity

artículo científico publicado en 2012

Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

artículo científico publicado en 2019

Nivolumab-induced thyroid dysfunction in patients with lung cancer

artículo científico publicado en 2018

Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity

artículo científico publicado en 2009

Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer.

artículo científico publicado en 2010

Obesity, fatty acid synthase, and cancer: serendipity or forgotten causal linkage?

artículo científico publicado en 2004

Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells

artículo científico publicado en 2008

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer

artículo científico publicado el 1 de octubre de 1997

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety stu

artículo científico publicado en 2017

Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).

artículo científico publicado en 2014

Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.

artículo científico publicado en 2008

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

artículo científico publicado en 2011

Prediction of response to targeted therapies in lung cancer using dynamic imaging: still far from clinical implementation.

artículo científico publicado en 2011

Predictors of unknown cancer in patients with ischemic stroke.

artículo científico publicado en 2018

Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey.

artículo científico publicado en 2012

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.

artículo científico publicado en 2011

Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.

artículo científico publicado en 2007

Real-world treatment in patients with HER2+ metastatic breast cancer : Treatment decisions in HER2+ mBC.

artículo científico publicado en 2017

Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents

scientific article published on 08 June 2019

Selection of extreme phenotypes: the role of clinical observation in translational research.

artículo científico publicado en 2010

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial

artículo científico publicado en 2014

Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome

artículo científico publicado en 2018

Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.

artículo científico publicado en 2009

Strategies to design clinical studies to identify predictive biomarkers in cancer research.

artículo científico publicado en 2016

Targeting cytoskeleton reorganisation as antimetastatic treatment.

scientific article published on October 2010

Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters.

artículo científico publicado en 2005

Validation of the 2001 St Gallen risk categories for node-negative breast cancer using a database from the Spanish Breast Cancer Research Group (GEICAM).

artículo científico publicado en 2004

Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?

artículo científico publicado en 2005

[Complications of intramuscular metastasis in a patient with lung cancer]

artículo científico publicado en 2010

[Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology]

artículo científico publicado en 2018

[Fatty acid synthase: a new anti-tumor target]

artículo científico publicado en 2009

[Vaccines and breast cancer]

scientific article published on 01 November 2008